Skip to main content

Unable to load price data. Sorry.


Altus Pharmaceuticals, Inc. (NASDAQ:ALTU.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for gastrointestinal and metabolic disorders, with two product candidates advancing toward late stage clinical development.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:ALTU.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

laKitKat (< 20)
Submitted March 12, 2007

52wk Range: 10.75 - 25.70Volume: 118,549Avg Vol (3m): 111,153Market Cap: 349.04MP/E (ttm): N/AEPS (ttm): -3.46Shares Outstanding: 22.95MIt utilizes its proprietary protein crystallization technology to develop protein therapies. The company�s lead… More

BustaCAPS (< 20)
Submitted June 20, 2008

Keys stats are horrible. I can make more profit by having a garage sale.



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ALTU.DL.

No one has written a Pitch for ALTU.DL stock yet. Tell us why you think ALTU.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in ALTU.DL.

No players have picked ALTU.DL yet. Tell us why you think ALTU.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ALTU.DL.